Paediatric Vaccine Market: Pneumococcal Indication Segment Anticipated to Be the Most Attractive Segment Through 2026: Global Industry Analysis and Opportunity Assessment, 2016-2026

  • Published: Dec, 2016
  • Report Code: REP-GB-1317

An Incisive, In-depth Analysis on the Pediatric Vaccines Market

This study offers a comprehensive, 360 degree analysis on the Pediatric Vaccines market, bringing to fore insights that can help stakeholders identify the opportunities as well as challenges. It tracks the global Pediatric Vaccines market across key regions, and offers in-depth commentary and accurate quantitative insights. The study also includes incisive competitive landscape analysis, and provides key recommendations to market players on winning imperatives and successful strategies.

Global Paediatric Vaccine Market: Towards a better and safer tomorrow

Paediatric vaccines are administered to a child in its paediatric age which is from 0 – 18 years of age. Vaccines are generally given in order to prevent children from diseases transferred through infections, seasonal variations and even through unhygienic areas. Depending upon disease, the vaccines are administered at regular intervals.  WHO has designed a standard immunization program in order to have desired time interval between vaccines doses.

Paediatric vaccines considered in the report include pneumococcal vaccine, DTP vaccine, rotavirus vaccine, MMR vaccine, polio vaccine, influenza vaccine, hepatitis B vaccine, Hib vaccine and meningococcal vaccine. Pneumococcal vaccine is administered to prevent the child from infectious diseases such as pneumonia. DTP vaccines is a combination vaccine administered against prevention of three diseases those are diphtheria, tetanus and pertussis. Hib vaccine is also a combination vaccine for hepatitis B and influenza and is widely accepted.

The market to expand manifold during the forecast period (2016 - 2026)

In terms of revenue, the global paediatric vaccine market is projected to expand at a CAGR of 12.2% during the forecast period and is expected to be valued at US$ 88.14 Bn by the end of 2026.

Revamped government policies to benefit the market, though soaring prices of vaccines to play spoilsport

The growth of the global paediatric vaccine market is primarily driven by increasing awareness regarding benefits of vaccination in prevention of diseases, rising economic growth, the collaboration of national manufacturers with key players in view to provide high-quality vaccines in at remote areas and initiative by global key players in developing innovative vaccines. In addition favourable reimbursement and increasing government support is expected to fuel the market growth over the forecast period. However, rising cost of vaccines, low accessibility to remote areas and increasing the availability of biosimilars at low rates might hinder the market growth over the forecast period.

The Pneumococcal segment to act as a catalyst in the overall market growth

Based on indication, the global paediatric vaccine market is segmented into pneumococcal vaccine, DTP vaccine, rotavirus vaccine, MMR vaccine, polio vaccine, influenza vaccine, hepatitis B vaccine, Hib vaccine and meningococcal vaccine. In terms of revenue share, the pneumococcal segment dominated the global paediatric vaccine market in 2015 and is expected to reach the cusp within the forecast period. The Hib segment is expected to witness relatively higher growth rates in terms of value in the global paediatric vaccine market over the forecast period.

Recombinant segment to face steep competition from the Conjugate segment within the forecast period

Based on technology, the global paediatric vaccine market is segmented into live or attenuated vaccine, inactivated or killed vaccines, conjugate vaccine, toxoid vaccine, subunit vaccine and recombinant vaccine. In terms of revenue share, the conjugate segment dominated the global paediatric vaccine market in 2015 and is expected to maintain the spike throughout the forecast period, registering higher CAGR as compared to the recombinant segment.

Monovalent vaccine segment to accumulate maximum market share

Based on vaccine type, the global paediatric vaccine market is segmented into monovalent vaccines and multivalent vaccines. Among these, monovalent vaccine segment held maximum market share in 2015 and expected to continue the trend throughout the forecast period.

The Institutional Health Centres segment to topple Hospital Pharmacy segment in the forecast period

Based on end user, the global paediatric vaccine market is segmented into hospital pharmacies, retail pharmacies and institutional health centres. Currently, institutional health centres segment accounts for relatively higher revenue share, followed by hospital pharmacy end user segment.

paediatric vaccine market_Image for preview analysis

North America market to lead the pack

The global paediatric vaccine market is segmented into seven major regions: North America, Latin America, Western Europe, Eastern Europe, APEJ (Asia Pacific excluding Japan), Japan and the Middle East & Africa (MEA). In terms of value, North America is expected to be the dominant regional market by 2016 end and is expected to expand at a CAGR of 11.0% over the forecast period. APEJ is expected to be the fastest growing market in terms of revenue growth in the global paediatric vaccine market, registering a CAGR of 14.9% over the forecast period.

Key stakeholders to create clamour in the market through mergers and revamped investment policies

Some key players in the global paediatric vaccine market included in this report are GlaxoSmithKline Plc., Merck & Co., Inc., Pfizer Inc., Sanofi, Panacea Biotec, Zydua Cadila, Emergent BioSolutions Inc., Serum Institute of India Pvt. Ltd., Bharat Biotech and Indian Immunologicals Ltd.

Future Market Insights offers a 10-year forecast for the global paediatric vaccine market. The primary objective of the report is to offer updates and information related to market opportunities in the global dermatology devices market.

Report Description

The primary objective of the report is to offer insights on the market dynamics that can influence growth of the global paediatric vaccine market over the forecast period. Insights on key trends, drivers, restraints, value forecasts and opportunities for companies operating in the global paediatric vaccine market are presented in the report.

To understand and assess opportunities in this market, the report offers market forecast on the basis of indication, technology, vaccine type, end user and regions. The report provides analysis of the global paediatric vaccine market in terms of market value (US$ Mn).

Market Segmentation

Region

 

Technology

 

Indication

 

End User

 

Vaccine Type

 

  • North America

  • Latin America

  • Western Europe

  • Eastern Europe

  • APEJ

  • MEA

  • Japan

  • Live or Attenuated Vaccine

  • Inactivated or Killed Vaccine

  • Toxoid Vaccine

  • Conjugate Vaccine

  • Subunit Vaccine

  • Recombinant Vector Vaccine

  • Pneumococcal Conjugate Vaccine

  • DTP Vaccine

  • Influenza

  • Meningococcal Vaccine

  • Polio Vaccine

  • Rotavirus Vaccine

  • MMR Vaccine

  • Varicella Virus Vaccine

  • Hospital Pharmacies

  • Retail Pharmacies

  • Institutional Health Centres

  • Monovalent Vaccines

  • Multivalent Vaccines

 

The report begins with the market definition, followed by definitions of the different indication of paediatric vaccine. The market dynamics section includes a comprehensive analysis on key trends, drivers, restraints, opportunities and macro-economic factors influencing the growth of the global paediatric vaccine market.

The next section of the report analyses the global paediatric vaccine market on the basis of technology and presents forecast in terms of value for the next 10 years. In addition, we have considered Year-on-Year (Y-o-Y) growth to understand the predictability of the market and identify growth opportunities for companies operating in the global paediatric vaccine market.

In the final section of the report, a ‘competitive landscape’ has been included to provide a dashboard view of key companies operating in the global paediatric vaccine market. This section is primarily designed to provide clients with an objective and detailed comparative assessment of key providers specific to a market segment in the global paediatric vaccine market and the potential players. However, this section also includes market strategies and SWOT analysis of the main players operational in the global paediatric vaccine market. Detailed profiles of paediatric vaccine manufacturers are also included in the scope of the report to evaluate their long- and short-term strategies.

What is our research methodology?

To deduce the market size of the global paediatric vaccine market, we have considered various viewpoints based on secondary research. Furthermore, data points such as regional split and market split in terms of services and parts, service provider, and vehicle type; and qualitative inputs from industry experts have been considered to arrive at suitable market estimates. The forecast presented in the report evaluates the actual revenue generated and expected revenue in the global paediatric vaccine market over the forecast period.

When developing the market forecast, the report begins with sizing the current market, which forms the basis for forecasting how the market is expected to grow during the forecast period. Given the characteristics of the market, we have triangulated the data on the basis of various analyses based on supply side, demand side, and other dynamics of the global paediatric vaccine market. Also, we understand the ever-fluctuating nature of the global economy and hence, we not only conduct forecasts in terms of CAGR, but also evaluate the market on the basis of key parameters such as year-on-year (Y-o-Y) growth to understand the predictability of the market and to identify growth opportunities for market players operating in the global paediatric vaccine market.

Another key feature of this report is the analysis of key segments in terms of absolute dollar opportunity. This is usually overlooked, while forecasting the market. However, absolute dollar opportunity is critical for assessing the level of opportunity that a provider can look to achieve, as well as to identify potential resources from a sales and delivery perspective for services offered by paediatric vaccine market. To understand key segments in terms of their growth and performance in the global paediatric vaccine market, Future Market Insights has developed a market attractiveness index. The resulting index would help providers identify existing market opportunities.

Analyst's Pick

Communicate and Connect

Secondary research plays a pivotal role in this research as the market is huge and it is constantly evolving with new innovations. We as a team not only searched for relevant information, but also spoke with some of the top honchos of vaccine manufacturing companies spread across the major healthcare economies of the world. This fetched some crucial and updated information about the market and provided a larger canvas to the research.

The striking point

The entire paediatric vaccine market is expected to surge within the forecast period. The North American region will lead the global growth of the paediatric vaccine market. But the blanket ban on MMR combination vaccine in Japan will have a massive impact on the market.

Combination vaccine: A new ray of hope 

The combination vaccine is holding the key to growth for the global paediatric vaccine market. The combination vaccine will slash the rising cost of vaccines and it will also expand the global periphery of the paediatric vaccine market.  

Pediatric Vaccines Market Reports - Table of Contents

Pediatric Vaccines Market Reports - List of Tables

Table 01: Global Paediatric Vaccine Market Value (US$ Mn) Forecast By Indication, 2015–2026

Table 02: Global Paediatric Vaccine Market Value (US$ Mn) Forecast By Technology, 2015–2026

Table 03: Global Paediatric Vaccine Market Value (US$ Mn) Forecast By Vaccine Type, 2015–2026

Table 04: Global Paediatric Vaccine Market Value (US$ Mn) Forecast By End Users, 2015–2026

Table 05: North America Paediatric Vaccine Market Value (US$ Mn) Forecast By Country, 2016–2026

Table 06: North America Paediatric Vaccine Market Value (US$ Mn) Forecast By Technology, 2016–2026

Table 07: North America Paediatric Vaccine Market Value (US$ Mn) Forecast By Vaccine Type, 2016–2026

Table 08: North America Balloon Catheter Market Value (US$ Mn) Forecast By Indication, 2016–2026

Table 09: North America Paediatric Vaccine Market Value (US$ Mn) Forecast By End Users, 2016–2026

Table 10: Latin America Pediatric Vaccine Market Value (US$ Mn) Forecast By Country, 2016–2026

Table 11: Latin America Paediatric Vaccine Market Value (US$ Mn) Forecast By Technology, 2016–2026

Table 12: Latin America Paediatric Vaccine Market Value (US$ Mn) Forecast By Vaccine Type, 2016–2026

Table 13: Latin America Paediatric Vaccine Market Value (US$ Mn) Forecast By Indication, 2016–2026

Table 14: Latin America Paediatric Vaccine Market Value (US$ Mn) Forecast By End Users, 2016–2026

Table 15: Eastern Europe Paediatric Vaccine Market Value (US$ Mn) Forecast By Country, 2016–2026

Table 16: Eastern Europe Paediatric Vaccine Market Value (US$ Mn) Forecast By Technology, 2016–2026

Table 17: Eastern Europe Paediatric Vaccine Market Value (US$ Mn) Forecast By Vaccine Type, 2016–2026

Table 18: Eastern Europe Paediatric Vaccine Market Value (US$ Mn) Forecast By Indication, 2016–2026

Table 19: Eastern Europe Paediatric Vaccine Market Value (US$ Mn) Forecast By End Users, 2016–2026

Table 20: Western Europe Paediatric Vaccine Market Value (US$ Mn) Forecast By Country, 2016–2026

Table 21: Western Europe Paediatric Vaccine Market Value (US$ Mn) Forecast By Technology, 2016–2026

Table 22: Western Europe Paediatric Vaccine Market Value (US$ Mn) Forecast By Vaccine Type, 2016–2026

Table 23: Western Europe Paediatric Vaccine Market Value (US$ Mn) Forecast By Indication, 2016–2026

Table 24: Western Europe Paediatric Vaccine Market Value (US$ Mn) Forecast By End Users, 2016–2026

Table 25: Asia Pacific Paediatric Vaccine Market Value (US$ Mn) Forecast By Country, 2016–2026

Table 26: Asia Pacific Paediatric Vaccine Market Value (US$ Mn) Forecast By Technology, 2016–2026

Table 27: Asia Pacific Paediatric Vaccine Market Value (US$ Mn) Forecast By Vaccine Type, 2016–2026

Table 28: Asia Pacific Paediatric Vaccine Market Value (US$ Mn) Forecast By Indication, 2016–2026

Table 29: Asia Pacific Paediatric Vaccine Market Value (US$ Mn) Forecast By End Users, 2016–2026

Table 30: Japan Paediatric Vaccine Market Value (US$ Mn) Forecast By Technology, 2016–2026

Table 31: Japan Paediatric Vaccine Market Value (US$ Mn) Forecast By Vaccine Type, 2016–2026

Table 32: Japan Paediatric Vaccine Market Value (US$ Mn) Forecast By Indication, 2016–2026

Table 33: Japan Paediatric Vaccine Market Value (US$ Mn) Forecast By End Users, 2016–2026

Table 34: Middle East and Africa Paediatric Vaccine Market Value (US$ Mn) Forecast By Country, 2016–2026

Table 35: Middle East and Africa Paediatric Vaccine Market Value (US$ Mn) Forecast By Technology, 2016–2026

Table 36: Middle East and Africa Paediatric Vaccine Market Value (US$ Mn) Forecast By Vaccine Type, 2016–2026

Table 37: Middle East and Africa Pediatric Vaccine Market Value (US$ Mn) Forecast By Indication, 2016–2026

Table 38: Middle East and Africa Paediatric Vaccine Market Value (US$ Mn) Forecast By End Users, 2016–2026

Pediatric Vaccines Market Reports - List of Figures

Figure 1: Global Paediatric Vaccine Market Value (US$ Mn) Forecast, 2015–2026 

Figure 2: Global Paediatric Vaccine Market Absolute $ Opportunity, 2015–2026 

Figure 3: Global Paediatric Vaccine Market Y-o-Y Growth, 2015–2026 

Figure above highlights market value, absolute $ opportunity, and Y-o-Y growth rate of the global pediatric vaccine market

Figure 4: Global Paediatric Vaccine Market – Scenario Forecast, 2016–2026 (US$ Mn)

Figure 5: Global Paediatric Vaccine Market share Analysis 2016, By Indication

Figure 6: Global Paediatric Vaccine Market share Analysis 2016, By Vaccine Type 

Figure 7: Global Paediatric Vaccine Market share Analysis 2016, By Technology 

Figure 8: Global Paediatric Vaccine Market Share Analysis (%) By Indication, 2016 & 2026

Figure 9: Global Paediatric Vaccine Market Y-o-Y Growth (%) By Indication, 2016–2026 

Figure 10: Global Paediatric Vaccine Market Y-o-Y Growth (%) By Indication, 2016–2026 

Figure 11: Global Paediatric Vaccine Market Absolute $ Opportunity (US$ Mn) By Pneumococcal Segment, 2016–2026

Figure 12: Global Paediatric Vaccine Market Absolute $ Opportunity (US$ Mn) By DTP Vaccine Segment, 2016–2026

Figure 13: Global Paediatric Vaccine Market Absolute $ Opportunity (US$ Mn) By Rotavirus Vaccine Segment, 2016–2026

Figure 14: Global Paediatric Vaccine Market Absolute $ Opportunity (US$ Mn) By MMR Vaccine Segment, 2016–2026

Figure 15: Global Paediatric Vaccine Market Absolute $ Opportunity (US$ Mn) By Polio Vaccine Segment, 2016–2026

Figure 16: Global Paediatric Vaccine Market Absolute $ Opportunity (US$ Mn) By Influenza Vaccine  Segment, 2016–2026

Figure 17: Global Paediatric Vaccine Market Absolute $ Opportunity (US$ Mn) By Hepatitis B Vaccine  Segment, 2016–2026

Figure 18: Global Paediatric Vaccine Market Absolute $ Opportunity (US$ Mn) By Meningococcal Vaccine Segment, 2016–2026

Figure 19: Global Paediatric Vaccine Market Absolute $ Opportunity (US$ Mn) By Hib Vaccine Segment, 2016–2026

Figure 20: Global Paediatric Vaccine Market Absolute $ Opportunity (US$ Mn) By Varicella Vaccine Segment, 2016–2026

Figure 21: Global Paediatric Vaccine Market Share Analysis (%) By Indication, 2016 & 2026

Figure 22: Global Paediatric Vaccine Market Y-o-Y Growth (%) By technology, 2016–2026 

Figure 23: Global Paediatric Vaccine Market Attractiveness Analysis By Technology, 2016–2026 

Figure 24: Global Paediatric Vaccine Market Absolute $ Opportunity (US$ Mn) By Live or Attenuated Segment, 2016–2026

Figure 25: Global Paediatric Vaccine Market Absolute $ Opportunity (US$ Mn) By Inactivated or Killed Segment, 2016–2026

Figure 26: Global Paediatric Vaccine Market Absolute $ Opportunity (US$ Mn) By Toxoid Vaccine Segment, 2016–2026

Figure 27: Global Paediatric Vaccine Market Absolute $ Opportunity (US$ Mn) By Conjugate Vaccine Segment, 2016–2026

Figure 28: Global Paediatric Vaccine Market Absolute $ Opportunity (US$ Mn) By Subunit Vaccine Segment, 2016–2026

Figure 29: Global Paediatric Vaccine Market Absolute $ Opportunity (US$ Mn) By Recombinant Vaccine  Segment, 2016–2026

Figure 30: Global Paediatric Vaccine Market Share Analysis (%) By Vaccine Type, 2016 & 2026

Figure 31: Global Paediatric Vaccine Market Y-o-Y Growth (%) By Vaccine Type, 2016–2026 

Figure 32: Global Paediatric Vaccine Market Attractiveness Analysis By Vaccine type, 2016–2026 

Figure 33: Global Paediatric Vaccine Market Absolute $ Opportunity (US$ Mn) By Monovalent Segment, 2016–2026

Figure 34: Global Paediatric Vaccine Market Absolute $ Opportunity (US$ Mn) By Multivalent  Segment,  2016–2026

Figure 35: Global Paediatric Vaccine Market Share Analysis (%) By End Users, 2016 & 2026

Figure 36: Global Paediatric Vaccine Market Y-o-Y Growth (%) By End Users, 2016–2026 

Figure 37: Global Paediatric Vaccine Market Attractiveness Analysis By End Users, 2016–2026 

Figure 38: Global Paediatric Vaccine Market Absolute $ Opportunity (US$ Mn) By Hospital Pharmacy Segment, 2016–2026

Figure 39: Global Paediatric Vaccine Market Absolute $ Opportunity (US$ Mn) By Retail Pharmacy Segment, 2016–2026

Figure 40: Global Paediatric Vaccine Market Absolute $ Opportunity (US$ Mn) By Institutional Health Centres Segment, 2016–2026

Figure 41: North America Paediatric Vaccine Market Share Analysis (%) By Country, 2016 & 2026

Figure 42: North America Paediatric Vaccine Market Attractiveness Analysis By Country, 2016–2026

Figure 43: North America Paediatric Vaccine Market Y-o-Y Growth (%) By Country, 2016–2026

Figure 44: North America Paediatric Vaccine Market Attractiveness Analysis By Technology, 2016–2026

Figure 45: North America Paediatric Vaccine Market Attractiveness Analysis By Vaccine Type, 2016–2026

Figure 46: North America Paediatric Vaccine Market Attractiveness Analysis By Indication, 2016–2026

Figure 47: North America Paediatric Vaccine Market Attractiveness Analysis By End Users,  2016–2026

Figure 48: Latin America Paediatric Vaccine Market Share Analysis (%) By Country, 2016 & 2026

Figure 49: Latin America Paediatric Vaccine Market Attractiveness Analysis By Country, 2016–2026

Figure 50: Latin America Paediatric Vaccine Market Y-o-Y Growth (%) By Country, 2016–2026

Figure 51: Latin America Paediatric Vaccine Market Attractiveness Analysis By Technology, 2016–2026

Figure 52: Latin America Paediatric Vaccine Market Attractiveness Analysis By Vaccine Type, 2016–2026

Figure 53: Latin America Paediatric Vaccine Market Attractiveness Analysis By Indication, 2016–2026

Figure 54: Latin America Paediatric Vaccine Market Attractiveness Analysis By End Users,  2016–2026

Figure 55: Eastern Europe Paediatric Vaccine Market Share Analysis (%) By Country, 2016 & 2026

Figure 56: Eastern Europe Paediatric Vaccine Market Attractiveness Analysis By Country, 2016–2026

Figure 57: Eastern Europe Paediatric Vaccine Market Y-o-Y Growth (%) By Country, 2016–2026

Figure 58: Eastern Europe Paediatric Vaccine Market Attractiveness Analysis By Technology, 2016–2026

Figure 59: Eastern Europe Paediatric Vaccine Market Attractiveness Analysis By Vaccine Type, 2016–2026

Figure 60: Eastern Europe Paediatric Vaccine Market Attractiveness Analysis By Indication, 2016–2026

Figure 61: Eastern Europe Paediatric Vaccine Market Attractiveness Analysis By End Users,  2016–2026

Figure 62: Western Europe Paediatric Vaccine Market Share Analysis (%) By Country, 2016 & 2026

Figure 63: Western Europe Paediatric Vaccine Market Attractiveness Analysis By Country, 2016–2026

Figure 64: Western Europe Paediatric Vaccine Market Y-o-Y Growth (%) By Country, 2016–2026

Figure 65: Western Europe Paediatric Vaccine Market Attractiveness Analysis By Technology, 2016–2026

Figure 66: Western Europe Paediatric Vaccine Market Attractiveness Analysis By Vaccine Type, 2016–2026

Figure 67: Western Europe Paediatric Vaccine Market Attractiveness Analysis By Indication, 2016–2026

Figure 68: Western Europe Paediatric Vaccine Market Attractiveness Analysis By End Users,  2016–2026

Figure 69: Asia Pacific Paediatric Vaccine Market Share Analysis (%) By Country, 2016 & 2026

Figure 70: Asia Pacific Paediatric Vaccine Market Attractiveness Analysis By Country, 2016–2026

Figure 71: Asia Pacific Paediatric Vaccine Market Y-o-Y Growth (%) By Country, 2016–2026

Figure 72: Asia Pacific Paediatric Vaccine Market Attractiveness Analysis By Technology, 2016–2026

Figure 73: Asia Pacific Paediatric Vaccine Market Attractiveness Analysis By Vaccine Type, 2016–2026

Figure 74: Asia Pacific Paediatric Vaccine Market Attractiveness Analysis By Indication, 2016–2026

Figure 75: Asia Pacific Paediatric Vaccine Market Attractiveness Analysis By End Users,  2016–2026

Figure 76: Japan Paediatric Vaccine Market Attractiveness Analysis By Technology, 2016–2026

Figure 77: Japan Paediatric Vaccine Market Attractiveness Analysis By Vaccine Type, 2016–2026

Figure 78: Japan Paediatric Vaccine Market Attractiveness Analysis By Indication, 2016–2026

Figure 79: Japan Paediatric Vaccine Market Attractiveness Analysis By End Users,  2016–2026

Figure 80: Middle East and Africa Paediatric Vaccine Market Share Analysis (%) By Country, 2016 & 2026

Figure 81: Middle East and Africa Paediatric Vaccine Market Attractiveness Analysis By Country, 2016–2026

Figure 82: Middle East and Africa Paediatric Vaccine Market Y-o-Y Growth (%) By Country, 2016–2026

Figure 83: Middle East and Africa Paediatric Vaccine Market Attractiveness Analysis By Technology, 2016–2026

Figure 84: Middle East and Africa Paediatric Vaccine Market Attractiveness Analysis By Vaccine Type, 2016–2026

Figure 85: Middle East and Africa Paediatric Vaccine Market Attractiveness Analysis By Indication, 2016–2026

Figure 86: Middle East and Africa Paediatric Vaccine Market Attractiveness Analysis By End Users,  2016–2026

Get in touch

Harish Tiwari

Global Head - Business Development

Pranay Mhaisekar

Business Development

Our Clients


CASE STUDIES

See how our work makes an impact.

At FMI, we design strategies that are adaptive, impactful, and implementable.

Request Sample Ask An Analyst Request Special Price Request Methodology